Emerging CT research suggests that the plexus pancreaticus capitalis 2 (PPC2) pathway or a mass with stranding morphology may significantly increase mortality risk in patients with pancreatic cancer and extra-pancreatic nerve plexus invasion (EPNI).
|Articles|April 12, 1995
Pharmacyclics inks manufacturing deal
MRI contrast developer Pharmacyclics of Sunnyvale, CA, has signed a contract manufacturing agreementwith Burroughs Wellcome for production of the company's Gadoliteagent. Pharmacyclics is developing Gadolite for enhancement ofMRI scans of the abdomen and
Advertisement
MRI contrast developer Pharmacyclics of Sunnyvale, CA, has signed a contract manufacturing agreementwith Burroughs Wellcome for production of the company's Gadoliteagent. Pharmacyclics is developing Gadolite for enhancement ofMRI scans of the abdomen and pelvis. The agent last month completedphase-three clinical trials and Pharmacyclics plans to submita new drug application in the middle of this year.
Advertisement
Related to this article
Catch up on the most-well viewed radiology content in October 2026.
In the second of a two-part podcast episode, Kalpana Kanal, PhD, and Mahadevappa Mahesh, PhD, discussed the possible impact of new research showing significant declines in CT radiation dosing over the past decade, future research directions and the potential for indication-based diagnostic reference levels (DRLs) in the future.
Emerging research suggests that the benefits of photon-counting CT may be more pronounced in patients with obesity.
Catch up on the most well-viewed radiology video interviews from Diagnostic Imaging in September 2026.
In the first of a two-part podcast episode, Kalpana Kanal, PhD, and Mahadevappa Mahesh, PhD, reviewed key findings from a study examining CT radiation dosing over the past decade and shared insights from their experience for ensuring optimal radiation dosing for CT scans.
In a new webinar program, Raj Chopra, MD and Peter Reilly share their insights on the importance of cybersecurity, keys to effective downtime communication, the ripple effects and costs of security breaches, challenges with AI and practical safeguards.
The AI-powered NeuroDR software reportedly removes bone, soft tissue and veins from CTA scans and provides subsequent 3D MIP views and curved planar reformatted views of carotid and vertebral arteries.
Advertisement
Advertisement